
Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (ccfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others), Material (Glass and Plastic), Applica
Description
Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (ccfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others), Material (Glass and Plastic), Application (In-Vitro Diagnostics (IVD) and Research), and End User (Genetic Diagnostic Labs, R&D Centres, Conventional Diagnostic Centres, and Others)
The Asia Pacific blood collection tubes for liquid biopsy market is expected to reach US$ 50.25 million by 2028 from US$ 14.93 million in 2021; it is estimated to grow at a CAGR of 18.9% from 2021-2028. The rising prevalence of cancer worldwide and the untapped potential of emerging economies are increasing the growth of the market. However, a lack of skilled professionals leading to inaccurate blood collection tubes for liquid biopsy analysis is restricting the market growth.
The rising demand for liquid biopsies for cancer diagnosis is increasing the sales of blood collection tubes for liquid biopsies. Leading market players increase their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets in India and South Korea are expected to offer potential growth opportunities for crucial blood collection tubes for liquid biopsy manufacturers in the years to come. This can be attributed to the large patient population, high prevalence of cancer types (such as skin, breasts, lungs, pancreas, and other organs and glands), increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries.
Asia Pacific has become a business-friendly and adaptable hub due to relatively less stringent regulations and data requirements. As the US and European markets mature, most players are shifting their focus to emerging markets. High investments in life science and health research in emerging countries play a key role in upgrading the latest technologies in these countries. This factor, in turn, supports the inclination toward a cancer diagnosis.
Health systems globally are witnessing a substantial increase in the prevalence of cancer. As per the Globocan report, in 2018, there were 911,014 breast cancer cases and 310,577 deaths due to breast cancer, of which 367,900 and 162,468 breast cancer cases were reported in China and India, respectively.
Liquid biopsies are used for diagnosing non-small cell lung cancer (NSCLC) and screening or as a companion diagnostic for other types of cancers such as colorectal, breast, gastrointestinal, prostate, and ovarian. Early prognosis, reduced cost, therapy monitoring, acquired drug resistance, detection of tumor heterogeneity, and patient comfort are benefits of liquid biopsy over traditional cancer diagnostics approaches (by eliminating the need for surgery). As a result, the preference for liquid biopsy increases parallelly with the rise in cancer prevalence. As a result, blood collection tubes for liquid biopsy contribute to the organization's strategy to detect cancer early and precisely, allowing for quick treatment and enhancing cancer patients' survival rates, thereby boosting the growth of the Asia Pacific blood collection tubes for liquid biopsy market.
The COVID-19 pandemic largely affected the economies in the Asia-Pacific region. Countries such as India, China, Japan, and South Korea had been affected by the COVID-19 pandemic. The spread of the COVID-19 pandemic emphasized health data sharing and interoperability under the microscope. The interruptions in the supply chain and the massive demand for efficient treatments for the therapy of COVID-19 had put the health research industry in the Asia-Pacific region in a crucial position.
Prohibited measures had been taken to contain the spread of the COVID-19 pandemic. The cancer screening, diagnosis, and treatment either got postponed or delayed due to the COVID-19 pandemic, thereby declining demand for blood collection tubes for liquid biopsy. In addition, the socio-economy was severely hit, with negative inflation, GDP, and unemployment rising in the region. The pandemic had affected three main aspects of the global economy, including manufacturing, supply chain, and business and financial markets. Japan, China, South Korea, India, and Australia were the hardest-hit countries due to the rising number of COVID-19 cases and related deaths. Medical device manufacturers and suppliers had shifted their focus to developing and supplying COVID-19 essentials and medical devices for respiratory diseases.
The Asia Pacific blood collection tubes for liquid biopsy market, based on product, has been classified into ccfDNA tubes, cfRNA tubes, CTC tubes, gDNA tubes, intracellular RNA tubes, and others. The ccfDNA segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR during the forecast period.
The Asia Pacific blood collection tubes for liquid biopsy market, based on material, is segmented into glass and plastic. In 2021, the plastic segment held a larger share of the market. However, the glass segment is expected to witness growth in demand at a faster CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions globally.
The Asia Pacific blood collection tubes for liquid biopsy market, based on application, is segmented into In-vitro diagnostics (ivd), and research. In 2021, the In-Vitro diagnostics segment is likely to hold a larger share of the market. Moreover, the segment is expected to witness growth in demand at a faster CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions globally.
A few of the primary and secondary sources referred to while preparing the report on the Asia Pacific blood collection tubes for liquid biopsy market are Global Burden of Disease (GBD) and World Health Organization (WHO).
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific blood collection tubes for liquid biopsy market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific blood collection tubes for liquid biopsy market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The Asia Pacific blood collection tubes for liquid biopsy market is expected to reach US$ 50.25 million by 2028 from US$ 14.93 million in 2021; it is estimated to grow at a CAGR of 18.9% from 2021-2028. The rising prevalence of cancer worldwide and the untapped potential of emerging economies are increasing the growth of the market. However, a lack of skilled professionals leading to inaccurate blood collection tubes for liquid biopsy analysis is restricting the market growth.
The rising demand for liquid biopsies for cancer diagnosis is increasing the sales of blood collection tubes for liquid biopsies. Leading market players increase their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets in India and South Korea are expected to offer potential growth opportunities for crucial blood collection tubes for liquid biopsy manufacturers in the years to come. This can be attributed to the large patient population, high prevalence of cancer types (such as skin, breasts, lungs, pancreas, and other organs and glands), increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries.
Asia Pacific has become a business-friendly and adaptable hub due to relatively less stringent regulations and data requirements. As the US and European markets mature, most players are shifting their focus to emerging markets. High investments in life science and health research in emerging countries play a key role in upgrading the latest technologies in these countries. This factor, in turn, supports the inclination toward a cancer diagnosis.
Health systems globally are witnessing a substantial increase in the prevalence of cancer. As per the Globocan report, in 2018, there were 911,014 breast cancer cases and 310,577 deaths due to breast cancer, of which 367,900 and 162,468 breast cancer cases were reported in China and India, respectively.
Liquid biopsies are used for diagnosing non-small cell lung cancer (NSCLC) and screening or as a companion diagnostic for other types of cancers such as colorectal, breast, gastrointestinal, prostate, and ovarian. Early prognosis, reduced cost, therapy monitoring, acquired drug resistance, detection of tumor heterogeneity, and patient comfort are benefits of liquid biopsy over traditional cancer diagnostics approaches (by eliminating the need for surgery). As a result, the preference for liquid biopsy increases parallelly with the rise in cancer prevalence. As a result, blood collection tubes for liquid biopsy contribute to the organization's strategy to detect cancer early and precisely, allowing for quick treatment and enhancing cancer patients' survival rates, thereby boosting the growth of the Asia Pacific blood collection tubes for liquid biopsy market.
The COVID-19 pandemic largely affected the economies in the Asia-Pacific region. Countries such as India, China, Japan, and South Korea had been affected by the COVID-19 pandemic. The spread of the COVID-19 pandemic emphasized health data sharing and interoperability under the microscope. The interruptions in the supply chain and the massive demand for efficient treatments for the therapy of COVID-19 had put the health research industry in the Asia-Pacific region in a crucial position.
Prohibited measures had been taken to contain the spread of the COVID-19 pandemic. The cancer screening, diagnosis, and treatment either got postponed or delayed due to the COVID-19 pandemic, thereby declining demand for blood collection tubes for liquid biopsy. In addition, the socio-economy was severely hit, with negative inflation, GDP, and unemployment rising in the region. The pandemic had affected three main aspects of the global economy, including manufacturing, supply chain, and business and financial markets. Japan, China, South Korea, India, and Australia were the hardest-hit countries due to the rising number of COVID-19 cases and related deaths. Medical device manufacturers and suppliers had shifted their focus to developing and supplying COVID-19 essentials and medical devices for respiratory diseases.
The Asia Pacific blood collection tubes for liquid biopsy market, based on product, has been classified into ccfDNA tubes, cfRNA tubes, CTC tubes, gDNA tubes, intracellular RNA tubes, and others. The ccfDNA segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR during the forecast period.
The Asia Pacific blood collection tubes for liquid biopsy market, based on material, is segmented into glass and plastic. In 2021, the plastic segment held a larger share of the market. However, the glass segment is expected to witness growth in demand at a faster CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions globally.
The Asia Pacific blood collection tubes for liquid biopsy market, based on application, is segmented into In-vitro diagnostics (ivd), and research. In 2021, the In-Vitro diagnostics segment is likely to hold a larger share of the market. Moreover, the segment is expected to witness growth in demand at a faster CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions globally.
A few of the primary and secondary sources referred to while preparing the report on the Asia Pacific blood collection tubes for liquid biopsy market are Global Burden of Disease (GBD) and World Health Organization (WHO).
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific blood collection tubes for liquid biopsy market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific blood collection tubes for liquid biopsy market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
144 Pages
- 1. Introduction
- 1.1 Study Scope
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - By Product
- 1.3.2 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - By Material
- 1.3.3 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - By Application
- 1.3.4 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - By End User
- 1.3.5 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - By Country
- 2. Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. Blood Collection Tubes for Liquid Biopsy Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis
- 4.3 Experts Opinion
- 5. Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cancer Worldwide
- 5.1.2 Rise in Demand for Minimally Invasive Diagnostic Tests
- 5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals Leading to Inaccurate Blood Collection for Liquid Biopsy Analysis
- 5.3 Market Opportunities
- 5.3.1 Untapped Potential of Emerging Economies
- 5.4 Future Trends
- 5.4.1 Technological Advancements in Blood Collection Tubes for Liquid Biopsy
- 5.5 Impact Analysis
- 6. Blood Collection Tubes for Liquid Biopsy Market- Asia Pacific Analysis
- 6.1 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Revenue Forecast and Analysis
- 7. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028- by Product
- 7.1 Overview
- 7.2 Blood Collection Tubes for Liquid Biopsy Market, By Product, 2021 & 2028 (%)
- 7.3 ccfDNA Tubes
- 7.3.1 Overview
- 7.3.2 ccfDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- 7.4 cfRNA Tubes
- 7.4.1 Overview
- 7.4.2 cfRNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- 7.5 CTC Tubes
- 7.5.1 Overview
- 7.5.2 CTC Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- 7.6 gDNA Tubes
- 7.6.1 Overview
- 7.6.2 gDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- 7.7 Intracellular RNA Tubes
- 7.7.1 Overview
- 7.7.2 Intracellular RNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- 7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- 8. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 - by Material
- 8.1 Overview
- 8.2 Blood Collection Tubes for Liquid Biopsy Market Share by Material - 2021 & 2028 (%)
- 8.3 Plastic
- 8.3.1 Overview
- 8.3.2 Plastic: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
- 8.4 Glass
- 8.4.1 Overview
- 8.4.2 Glass: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
- 9. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 - by Application
- 9.1 Overview
- 9.2 Blood Collection Tubes for Liquid Biopsy Market Share by Application - 2021 & 2028 (%)
- 9.3 In-Vitro Diagnostics (IVD)
- 9.3.1 Overview
- 9.3.2 In-Vitro Diagnostics (IVD): Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
- 9.4 Research
- 9.4.1 Overview
- 9.4.2 Research: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
- 10. Asia Paciifc Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 - by End-User
- 10.1 Overview
- 10.2 Blood Collection Tubes for Liquid Biopsy Market Share by End User - 2021 & 2028 (%)
- 10.3 Genetic Diagnostic Labs
- 10.3.1 Overview
- 10.3.2 Genetic Diagnostic Labs: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
- 10.4 R&D Centres
- 10.4.1 Overview
- 10.4.2 R&D Centres: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
- 10.5 Conventional Diagnostic Centres
- 10.5.1 Overview
- 10.5.2 Conventional diagnostic centres: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
- 10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
- 11. Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 -Asia Pacific Analysis
- 11.1 Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market
- 11.1.1 Overview
- 11.1.2 Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.3 Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Product, 2019-2028 (US$ Thousand)
- 11.1.4 Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Material, 2019-2028 (US$ Thousand)
- 11.1.5 Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, Application, 2019-2028 (US$ Thousand)
- 11.1.6 Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By End User, 2019-2028 (US$ Thousand)
- 11.1.7 Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, by Country, 2021 & 2028 (%)
- 11.1.7.1 China: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.1.1 China: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.1.2 China: Blood Collection Tubes For Liquid Biopsy Market, By Product, 2019-2028 (US$ Thousand)
- 11.1.7.1.3 China: Blood Collection Tubes For Liquid Biopsy Market, By Material, 2019-2028 (US$ Thousand)
- 11.1.7.1.4 China: Blood Collection Tubes For Liquid Biopsy Market, By Application, 2019-2028 (US$ Thousand)
- 11.1.7.1.5 China: Blood Collection Tubes For Liquid Biopsy Market, By End User, 2019-2028 (US$ Thousand)
- 11.1.7.2 Japan: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.2.1 Japan: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.2.2 Japan: Blood Collection Tubes For Liquid Biopsy Market, By Product, 2019-2028 (US$ Thousand)
- 11.1.7.2.3 Japan: Blood Collection Tubes For Liquid Biopsy Market, By Material, 2019-2028 (US$ Thousand)
- 11.1.7.2.4 Japan: Blood Collection Tubes For Liquid Biopsy Market, By Application, 2019-2028 (US$ Thousand)
- 11.1.7.2.5 Japan: Blood Collection Tubes For Liquid Biopsy Market, By End User, 2019-2028 (US$ Thousand)
- 11.1.7.3 India: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.3.1 India: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.3.2 India: Blood Collection Tubes For Liquid Biopsy Market, By Product, 2019-2028 (US$ Thousand)
- 11.1.7.3.3 India: Blood Collection Tubes For Liquid Biopsy Market, By Material, 2019-2028 (US$ Thousand)
- 11.1.7.3.4 India: Blood Collection Tubes For Liquid Biopsy Market, By Application, 2019-2028 (US$ Thousand)
- 11.1.7.3.5 India: Blood Collection Tubes For Liquid Biopsy Market, By End User, 2019-2028 (US$ Thousand)
- 11.1.7.4 Australia: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.4.1 Australia: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.4.2 Australia: Blood Collection Tubes For Liquid Biopsy Market, By Product, 2019-2028 (US$ Thousand)
- 11.1.7.4.3 Australia: Blood Collection Tubes For Liquid Biopsy Market, By Material, 2019-2028 (US$ Thousand)
- 11.1.7.4.4 Australia: Blood Collection Tubes For Liquid Biopsy Market, By Application, 2019-2028 (US$ Thousand)
- 11.1.7.4.5 Australia: Blood Collection Tubes For Liquid Biopsy Market, By End User, 2019-2028 (US$ Thousand)
- 11.1.7.5 South Korea: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.5.1 South Korea: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.5.2 South Korea: Blood Collection Tubes For Liquid Biopsy Market, By Product, 2019-2028 (US$ Thousand)
- 11.1.7.5.3 South Korea: Blood Collection Tubes For Liquid Biopsy Market, By Material, 2019-2028 (US$ Thousand)
- 11.1.7.5.4 South Korea: Blood Collection Tubes For Liquid Biopsy Market, By Application, 2019-2028 (US$ Thousand)
- 11.1.7.5.5 South Korea: Blood Collection Tubes For Liquid Biopsy Market, By End User, 2019-2028 (US$ Thousand)
- 11.1.7.6 Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.6.1 Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- 11.1.7.6.2 Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Product, 2019-2028 (US$ Thousand)
- 11.1.7.6.3 Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Material, 2019-2028 (US$ Thousand)
- 11.1.7.6.4 Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Application, 2019-2028 (US$ Thousand)
- 11.1.7.6.5 Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By End User, 2019-2028 (US$ Thousand)
- 12. Impact Of COVID-19 Pandemic on Blood Collection Tubes for Liquid Biopsy Market
- 12.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
- 13. Blood Collection Tubes for Liquid Biopsy Market-Industry Landscape
- 13.1 Overview
- 13.2 Organic Developments
- 13.2.1 Overview
- 13.3 Inorganic Developments
- 13.3.1 Overview
- 14. Company Profiles
- 14.1 PreAnalytiX GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Biocept, Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 F. HOFFMANN-LA ROCHE LTD.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 STRECK
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Norgen Biotek Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Exact Sciences Corporation
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Greiner AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 MagBio Genomics, Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Zymo Research Corporation
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms
- list of Tables
- Table 1. Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Product - Revenue and Forecast to 2028 (US$ Thousand)
- Table 2. Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Material - Revenue and Forecast to 2028 (US$ Thousand)
- Table 3. Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Application - Revenue and Forecast to 2028 (US$ Thousand)
- Table 4. Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By End User - Revenue and Forecast to 2028 (US$ Thousand)
- Table 5. China: Blood Collection Tubes For Liquid Biopsy Market, By Product - Revenue and Forecast to 2028 (US$ Thousand)
- Table 6. China: Blood Collection Tubes For Liquid Biopsy Market, By Material - Revenue and Forecast to 2028 (US$ Thousand)
- Table 7. China: Blood Collection Tubes For Liquid Biopsy Market, By Application- Revenue and Forecast to 2028 (US$ Thousand)
- Table 8. China: Blood Collection Tubes For Liquid Biopsy Market, By End User- Revenue and Forecast to 2028 (US$ Thousand)
- Table 9. Japan: Blood Collection Tubes For Liquid Biopsy Market, By Product - Revenue and Forecast to 2028 (US$ Thousand)
- Table 10. Japan: Blood Collection Tubes For Liquid Biopsy Market, By Material- Revenue and Forecast to 2028 (US$ Thousand)
- Table 11. Japan: Blood Collection Tubes For Liquid Biopsy Market, By Application- Revenue and Forecast to 2028 (US$ Thousand)
- Table 12. Japan: Blood Collection Tubes For Liquid Biopsy Market, By End User- Revenue and Forecast to 2028 (US$ Thousand)
- Table 13. India: Blood Collection Tubes For Liquid Biopsy Market, By Product- Revenue and Forecast to 2028 (US$ Thousand)
- Table 14. India: Blood Collection Tubes For Liquid Biopsy Market, By Material- Revenue and Forecast to 2028 (US$ Thousand)
- Table 15. India: Blood Collection Tubes For Liquid Biopsy Market, By Application- Revenue and Forecast to 2028 (US$ Thousand)
- Table 16. India: Blood Collection Tubes For Liquid Biopsy Market, By End User- Revenue and Forecast to 2028 (US$ Thousand)
- Table 17. Australia: Blood Collection Tubes For Liquid Biopsy Market, By Product - Revenue and Forecast to 2028 (US$ Thousand)
- Table 18. Australia: Blood Collection Tubes For Liquid Biopsy Market, By Material - Revenue and Forecast to 2028 (US$ Thousand)
- Table 19. Australia: Blood Collection Tubes For Liquid Biopsy Market, By Application - Revenue and Forecast to 2028 (US$ Thousand)
- Table 20. Australia: Blood Collection Tubes For Liquid Biopsy Market, By End User - Revenue and Forecast to 2028 (US$ Thousand)
- Table 21. South Korea: Blood Collection Tubes For Liquid Biopsy Market, By Product - Revenue and Forecast to 2028 (US$ Thousand)
- Table 22. South Korea: Blood Collection Tubes For Liquid Biopsy Market, By Material - Revenue and Forecast to 2028 (US$ Thousand)
- Table 23. South Korea: Blood Collection Tubes For Liquid Biopsy Market, By Application - Revenue and Forecast to 2028 (US$ Thousand)
- Table 24. South Korea: Blood Collection Tubes For Liquid Biopsy Market, By End User - Revenue and Forecast to 2028 (US$ Thousand)
- Table 25. Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Product - Revenue and Forecast to 2028 (US$ Thousand)
- Table 26. Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Material - Revenue and Forecast to 2028 (US$ Thousand)
- Table 27. Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By Application - Revenue and Forecast to 2028 (US$ Thousand)
- Table 28. Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, By End User - Revenue and Forecast to 2028 (US$ Thousand)
- Table 29. Organic Developments Done By Companies
- Table 30. Inorganic Developments Done By Companies
- Table 31. Glossary of Terms
- List of Figures
- Figure 1. Blood Collection Tubes for Liquid Biopsy Market Segmentation
- Figure 2. Blood Collection Tubes for Liquid Biopsy Market, By Country
- Figure 3. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Overview
- Figure 4. CcfDNA Tubes Segment Held Largest Share of Product Segment in Blood Collection Tubes for Liquid Biopsy Market
- Figure 5. China Blood Collection Tubes for Liquid Biopsy Market- Leading Country Markets (US$ ‘000)
- Figure 6. Asia Pacific: PEST Analysis
- Figure 7. Experts Opinion
- Figure 8. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market- Revenue Forecast and Analysis - 2021 - 2028
- Figure 9. Blood Collection Tubes for Liquid Biopsy Market, by Product, 2021 & 2028 (%)
- Figure 10. CcfDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- Figure 11. cfRNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- Figure 12. CTC Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- Figure 13. gDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- Figure 14. Intracellular RNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- Figure 15. Others: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
- Figure 16. Blood Collection Tubes for Liquid Biopsy Market Share by Material - 2021 & 2028 (%)
- Figure 17. Plastic: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
- Figure 18. Glass: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
- Figure 19. Blood Collection Tubes for Liquid Biopsy Market Share by Application - 2021 & 2028 (%)
- Figure 20. In-Vitro Diagnostics (IVD): Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
- Figure 21. Research: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
- Figure 22. Blood Collection Tubes for Liquid Biopsy Market Share by End User - 2021 & 2028 (%)
- Figure 23. Genetic Diagnostic Labs: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
- Figure 24. R&D Centres: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
- Figure 25. Conventional diagnostic centres: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
- Figure 26. Others: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
- Figure 27. Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, by Key Country - Revenue (2021) (US$ Thousand)
- Figure 28. Asia Pacific Blood Collection Tubes For Liquid Biopsy Market Revenue and Forecast to 2028 (US$ Thousand)
- Figure 29. Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market, by Country, 2021 & 2028 (%)
- Figure 30. China: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- Figure 31. Japan: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- Figure 32. India: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- Figure 33. Australia: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- Figure 34. South Korea: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- Figure 35. Rest of Asia Pacific: Blood Collection Tubes For Liquid Biopsy Market - Revenue and Forecast to 2028 (US$ Thousand)
- Figure 36. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.